Omron Ventures

Omron Ventures is the corporate venture capital arm of Omron Corporation, established on July 1, 2014, to accelerate the creation of new businesses by investing in startups worldwide. The firm aims to integrate Omron's core technologies with innovative ideas from entrepreneurs to address societal challenges. Omron Ventures has committed to investing approximately 3 billion yen over the three-year period from fiscal 2014 to 2016.

The investment strategy of Omron Ventures focuses on areas such as factory automation, smart cities, digital health, and energy management. The firm seeks to support startups that are developing solutions to complex social issues, leveraging Omron's expertise in sensing and control technologies. Notable investments include a strategic partnership with Sky Labs, a South Korean company specializing in continuous blood pressure monitoring devices, and a Series B funding round for Theranica Bio-Electronics, an Israeli startup developing remote electrical neuromodulation devices for acute migraine treatment.

Omron Ventures operates with a long-term perspective, aiming to foster open innovation and collaboration with startups to drive societal progress. The firm emphasizes the importance of joint development with external businesses to create new value and address global challenges. By investing in early-stage companies, Omron Ventures contributes to the growth of innovative solutions that align with Omron's mission to improve lives through technology.